Get startedLog in
    Picture of Scribe Therapeutics logo

    SCTX — Scribe Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing

    Picture of Scribe Therapeutics logoScribe Therapeutics
    20/07/2026 12:27
    BRIEF-Scribe Therapeutics - IPO Price Expected Between $13 And $15 Per Share - SEC Filing
    July 20 (Reuters) - Scribe Therapeutics Inc SCTX.O:
    • SCRIBE THERAPEUTICS - IPO PRICE EXPECTED BETWEEN $13 AND $15 PER SHARE - SEC FILING
    • SCRIBE THERAPEUTICS - LAUNCHES IPO OF 7,150,000 COMMON SHARES - SEC FILING
    • SCRIBE THERAPEUTICS - AVENTIS AND GENZYME TO PURCHASE $7.50 MILLION IN SHARES VIA CONCURRENT PRIVATE PLACEMENT - SEC FILING
    • SCRIBE THERAPEUTICS INC - ELI LILLY HAS INDICATED INTEREST IN PURCHASING CO'S SHARES OF COMMON STOCK AT IPO PRICE
    Source text: [ID:n0001193125-26-308330]
    Further company coverage: SCTX.O

     ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Scribe Therapeutics

    See all news